| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |